 Study design considerations ribavirin efficacy studies placebo-controlled double-blind studies subjects question effect aerosolized ribavirin course RSV respiratory infection infancy fact able beneficial effect small number subjects evidence effect studies Rochester oximetry analog illness severity scale effect significant relevant tools reliable applicable measures multicenter studies illness severity outcome measure Characteristics consideration experimental groups age sex history prematurity underlying conditions arterial oxygen saturation Future studies additional questions efficacy ribavirin role ill children economic benefits use terms duration hospitalization usefulness early treatment RSV disease high risk infants impact treatment long-term consequences RSV infection studies outcome variables subject selection strategies different studies